NasdaqCM - Delayed Quote USD
Celcuity Inc. (CELC)
12.91
-0.14
(-1.07%)
At close: 4:00:00 PM EDT
12.91
0.00
(0.00%)
After hours: 4:20:00 PM EDT
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 1 | 1 | 1 | 1 |
Avg. Estimate | -0.86 | -0.88 | -3.51 | -3.15 |
Low Estimate | -0.86 | -0.88 | -3.51 | -3.15 |
High Estimate | -0.86 | -0.88 | -3.51 | -3.15 |
Year Ago EPS | -0.58 | -0.65 | -2.58 | -3.51 |
Revenue Estimate
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 6 | 6 | 6 | 6 |
Avg. Estimate | -- | -- | -- | 39.99M |
Low Estimate | -- | -- | -- | 21.5M |
High Estimate | -- | -- | -- | 93.9M |
Year Ago Sales | -- | -- | -- | -- |
Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
---|---|---|---|---|
EPS Est. | -0.55 | -0.7 | -0.67 | -0.86 |
EPS Actual | -0.58 | -0.65 | -0.75 | -0.81 |
Difference | -0.03 | 0.05 | -0.08 | 0.05 |
Surprise % | -5.45% | 7.14% | -11.94% | 5.81% |
EPS Trend
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | -0.86 | -0.88 | -3.51 | -3.15 |
7 Days Ago | -0.86 | -0.89 | -3.57 | -2.86 |
30 Days Ago | -0.86 | -0.89 | -3.57 | -2.86 |
60 Days Ago | -0.75 | -0.77 | -3.11 | -2.71 |
90 Days Ago | -0.75 | -0.77 | -3.11 | -2.71 |
EPS Revisions
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | 1 | 1 | -- |
Up Last 30 Days | -- | 1 | 1 | -- |
Down Last 7 Days | 1 | -- | -- | 1 |
Down Last 30 Days | 1 | -- | -- | 1 |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
CELC | -48.28% | -35.38% | -36.05% | 10.26% |
S&P 500 | 13.13% | 2.46% | 7.55% | 14.08% |
Upgrades & Downgrades
Reiterates | HC Wainwright & Co.: Buy to Buy | 5/19/2025 |
Reiterates | Needham: Buy to Buy | 5/15/2025 |
Reiterates | Needham: Buy to Buy | 4/11/2025 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 4/1/2025 |
Reiterates | Needham: Buy to Buy | 4/1/2025 |
Maintains | Needham: Buy to Buy | 2/6/2025 |
Related Tickers
IDYA IDEAYA Biosciences, Inc.
21.71
-0.09%
NUVL Nuvalent, Inc.
76.08
-2.49%
IMTX Immatics N.V.
6.00
+0.50%
ANAB AnaptysBio, Inc.
23.19
-2.15%
TYRA Tyra Biosciences, Inc.
10.26
-2.75%
BCAX Bicara Therapeutics Inc.
11.48
-0.17%
MLYS Mineralys Therapeutics, Inc.
16.19
+0.43%
DSGN Design Therapeutics, Inc.
3.9100
-2.49%
CGEM Cullinan Therapeutics, Inc.
8.76
-3.52%
COGT Cogent Biosciences, Inc.
6.90
+1.47%